1-9 of 9
Jin Soo Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy

Tony Mok, Yi-Long Wu, Jin Soo Lee, Chong-Jen Yu, Virote Sriuranpong, Jennifer Sandoval-Tan, Guia Ladrera, Sumitra Thongprasert, Vichien Srimuninnimit, Meilin Liao, Yunzhong Zhu, Caicun Zhou, Fatima Fuerte, Benjamin Margono, Wei Wen, Julie Tsai, Matt Truman, Barbara Klughammer, David S. Shames, Lin Wu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (14): 3196–3203.
https://doi.org/10.1158/1078-0432.CCR-14-2594
Published: 14 July 2015
View article titled, Detection and Dynamic Changes of <em>EGFR</em> Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
Open the PDF for Detection and Dynamic Changes of <em>EGFR</em> Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Genetic Variations Associated with Postoperative Recurrence in Stage I Non–Small Cell Lung Cancer

Kyong-Ah Yoon, Mee Kyung Jung, Donghoon Lee, Kieun Bae, Jung Nam Joo, Geon Kook Lee, Hyun-Sung Lee, Jin Soo Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (12): 3272–3279.
https://doi.org/10.1158/1078-0432.CCR-13-2835
Published: 12 June 2014
View article titled, Genetic Variations Associated with Postoperative Recurrence in Stage I Non–Small Cell Lung Cancer
Open the PDF for Genetic Variations Associated with Postoperative Recurrence in Stage I Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy

Young Joo Lee, Kyong-Ah Yoon, Ji-Youn Han, Heung Tae Kim, Tak Yun, Geon Kook Lee, Hyae Young Kim, Jin Soo Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5179–5187.
https://doi.org/10.1158/1078-0432.CCR-11-0400
Published: 31 July 2011
View article titled, Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy
Open the PDF for Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer

Ji-Youn Han, Soo-Hyun Lee, Nam Jin Yoo, Lee Suk Hyung, Yoon Joo Moon, Tak Yun, Heung Tae Kim, Jin Soo Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (6): 1553–1560.
https://doi.org/10.1158/1078-0432.CCR-10-2525
Published: 15 March 2011
View article titled, A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer
Open the PDF for A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer in another window
Journal Articles

Radiosensitivity Enhancement by Combined Treatment of Celecoxib and Gefitinib on Human Lung Cancer Cells

Ji Sun Park, Hyun Jung Jun, Moon Jun Cho, Kwan Ho Cho, Jin Soo Lee, Jae Ill Zo, Hongryull Pyo
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (16): 4989–4999.
https://doi.org/10.1158/1078-0432.CCR-05-2259
Published: 16 August 2006
View article titled, Radiosensitivity Enhancement by Combined Treatment of Celecoxib and Gefitinib on Human Lung Cancer Cells
Open the PDF for Radiosensitivity Enhancement by Combined Treatment of Celecoxib and Gefitinib on Human Lung Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Gefitinib as a First-Line Therapy of Advanced or Metastatic Adenocarcinoma of the Lung in Never-Smokers

Dae Ho Lee, Ji-Youn Han, Hong Gi Lee, Jae Jin Lee, Eun Kyoung Lee, Hyae Young Kim, Hark Kyun Kim, Eun Kyung Hong, Jin Soo Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (8): 3032–3037.
https://doi.org/10.1158/1078-0432.CCR-04-2149
Published: 18 April 2005
View article titled, Gefitinib as a First-Line Therapy of Advanced or Metastatic Adenocarcinoma of the Lung in Never-Smokers
Open the PDF for Gefitinib as a First-Line Therapy of Advanced or Metastatic Adenocarcinoma of the Lung in Never-Smokers in another window
Journal Articles

A Phase II Study of Weekly Irinotecan and Capecitabine in Patients with Previously Treated Non-Small Cell Lung Cancer

Ji-Youn Han, Dae Ho Lee, Hyae Young Kim, Eun-A Kim, Jae Jin Lee, So Young Ju, Eun Hee Shin, Jin Soo Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5909–5914.
Published: 15 December 2003
View article titled, A Phase II Study of Weekly Irinotecan and Capecitabine in Patients with Previously Treated Non-Small Cell Lung Cancer
Open the PDF for A Phase II Study of Weekly Irinotecan and Capecitabine in Patients with Previously Treated Non-Small Cell Lung Cancer in another window
Journal Articles

A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer

Charles Lu, Ritsuko Komaki, Jin Soo Lee, Dong M. Shin, J. Lynn Palmer, Brenda J. Coldman, Katherine M. Pisters, Jonathan M. Kurie, Frank V. Fossella, Bonnie S. Glisson
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2085–2091.
Published: 01 June 2003
View article titled, A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer
Open the PDF for A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer in another window
Journal Articles

Response and Determinants of Sensitivity to Paclitaxel in Human Non-Small Cell Lung Cancer Tumors Heterotransplanted in Nude Mice

Roman Perez-Soler, Bonnie Kemp, Qing Ping Wu, Li Mao, Jorge Gomez, Anne Zeleniuch-Jacquotte, Herman Yee, Jin Soo Lee, Jaishree Jagirdar, Yi He Ling
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4932–4938.
Published: 01 December 2000
View article titled, Response and Determinants of Sensitivity to Paclitaxel in Human Non-Small Cell Lung Cancer Tumors Heterotransplanted in Nude Mice
Open the PDF for Response and Determinants of Sensitivity to Paclitaxel in Human Non-Small Cell Lung Cancer Tumors Heterotransplanted in Nude Mice in another window